These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24369021)

  • 1. [The fight against counterfeit drugs].
    Bruhn C
    Dtsch Med Wochenschr; 2013 Nov; 138(47):2396-7. PubMed ID: 24369021
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
    Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
    [No Abstract]   [Full Text] [Related]  

  • 3. The hunt for counterfeit medicine. Drugs manufactured by counterfeiters are infiltrating markets worldwide. Investigators are harnessing a variety of analytical techniques to catch as many of the fakes as they can.
    Mukhopadhyay R
    Anal Chem; 2007 Apr; 79(7):2622-7. PubMed ID: 17476727
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Aktuelle Urol; 2017 Feb; 48(1):25-26. PubMed ID: 28403489
    [No Abstract]   [Full Text] [Related]  

  • 5. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterfeit pharmaceuticals: murder by medicine.
    Aldhous P
    Nature; 2005 Mar; 434(7030):132-6. PubMed ID: 15758966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Naming and packaging of pharmaceutical products].
    Bruhn C
    Dtsch Med Wochenschr; 2013 Nov; 138(46):2340-1. PubMed ID: 24350365
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars.
    Gitter DM
    Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759
    [No Abstract]   [Full Text] [Related]  

  • 9. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 10. Counterfeit pharmaceuticals: in the line of fire. Dora Akunyili interviewed by Peter Aldhous.
    Akunyili D
    Nature; 2005 Mar; 434(7030):134. PubMed ID: 15758967
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulatory experts debate FDA's authority.
    Young D
    Am J Health Syst Pharm; 2007 May; 64(9):910, 912. PubMed ID: 17468140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
    Hurtado RL; Lasmar MC
    Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the drugstore safe? Counterfeit diabetes products on the shelves.
    Cheng MM
    J Diabetes Sci Technol; 2009 Nov; 3(6):1516-20. PubMed ID: 20144408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curbing the circulation of counterfeit medicines in Nigeria.
    Fatokun O
    Lancet; 2016 Nov; 388(10060):2603. PubMed ID: 27832872
    [No Abstract]   [Full Text] [Related]  

  • 15. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication safety issue brief. Counterfeit drug prevention and identification.
    ; ;
    Hosp Health Netw; 2005 Aug; 79(8):29-30. PubMed ID: 16247941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Materials and Technologies to Combat Counterfeiting of Pharmaceuticals: Current and Future Problem Tackling.
    Zhang H; Hua D; Huang C; Samal SK; Xiong R; Sauvage F; Braeckmans K; Remaut K; De Smedt SC
    Adv Mater; 2020 Mar; 32(11):e1905486. PubMed ID: 32009266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerned about unlicensed practice.
    Allen JM
    J Am Vet Med Assoc; 1991 Sep; 199(6):679. PubMed ID: 1955352
    [No Abstract]   [Full Text] [Related]  

  • 19. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].
    Tamir O; Friedman N; Furman-Assaf S; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):466-9, 479. PubMed ID: 21465763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.